In the first half of October 2025, Troxerutin prices throughout Asia recovered after a 1.30% fall in September (FOB Shanghai), as the demand for the product increased as Chinese and Indian restocking activity started. The previous slide was the result of an oversupply situation, low Rutin costs and a clear-out of stocks prior to the Chinese Golden Week holidays, which caused pressure on trading assessments. In India low priced offers from Chinese exporters and sufficient stocks available resulted in a lack of fresh buying activity. However, in the domestic market there was steady consumption, which helped to support the overall base of consumption. The improvement in the market during October took place gradually as importers started restocking activity along with stronger downstream demand. Rapid recovery in Chinese manufacturing after the holiday period, coupled with regular buying activity visible in other Asian markets provided the necessary back-up for a rising of offers. Market analysts suggest that Troxerutin prices will rise further in the second half of October as restocking continues, along with new export enquiry and steady overall demand indicating that a gradual recovery of the regional market can be anticipated.
Troxerutin prices in the Asian market rebounded by the first half of October 2025 after plummeting by 1.3% in September in FOB Shanghai (China), due to renewed demand and restocking activity - especially in China and India. This recovery came on the heels of a rough period where prices were weighed down by soft feedstocks, high inventory levels and a general slowdown in international buying. As Troxerutin demand from the pharmaceutical and nutraceutical industries picked up steam again, the Troxerutin market started to even out across the major Asian economies.
Troxerutin prices took a nosedive in September 2025, due to an oversupply problem and weak buying interest ahead of the China holidays in September. Chinese manufacturers were looking to get rid of stockpiles that had been piling up during previous production cycles, so they started offering some discounts in Troxerutin prices. Weakness in Rutin feedstock prices declined the production cost. Despite the steady freight rates, the mood on the market was bearish because global buyers were being cautious and waiting it out given all the trade uncertainty and the cautiousness in the new enquires for Troxerutin.
In India, Troxerutin prices were also down in September - a result of cheap Chinese export prices and no urgent need to buy more. Distributors in the main hubs like Mumbai and Ahmedabad still had plenty of stock after they'd stockpiled so had no reason to go on a restocking spree during that month - however, there was a baseline of support from steady domestic consumption of Troxerutin for the sorts of treatments, so the price drop was limited.
The first half of October was a real turnaround - restocking was getting back underway across Asia, with importers in India and Southeast Asia leading the way. With Troxerutin inventories running a bit low after a period of slow trading, buyers started restocking and the ongoing demand downstream stayed consistent. Over in China, manufacturers were back in gear after the holidays, and noticing a bit of an increase in interest from international buyers started bumping up their export prices for Troxerutin - which all helped make the market a bit more stable.
The recovery was further supported by improving procurement and steady demand of Troxerutin from pharma and nutraceutical segments. Troxerutin continued to be a key ingredient in vascular health formulations and antioxidant supplements, so there was a steady base of consumption in Asian markets. Better logistics, stable exchange rates and low freight cost ensured smooth trade flow between China and India, so cross border supply chain was reliable. With production and demand balanced, Troxerutin prices started to reflect better fundamentals than the oversupply in September.
Analysts say the recent rebound is a shift from short term correction to long term stabilization of Asian Troxerutin market. In both China and India, Troxerutin producers and importers have shown better sync between supply and demand, so price volatility is reducing. Normalization of feedstock cost and consistent overseas inquiry have helped to balance the market, with export interest from Middle East and Southeast Asia added to the optimism.
Looking forward, Troxerutin prices in Asia will continue to rise moderately in 2nd half of October 2025. Prices will strengthen as restocking align with production cycle and downstream demand is steady in both China and India. Supply is stable, procurement is improving and buyer sentiment is firm so seller offers will be stronger. Export enquiry will remain constructive so transaction will be active across regional markets. With these positive factors, Asian Troxerutin market is expected to be gradual but resilient uptrend for the rest of the month.
